Inhibition of cell surface GRP78 and activated α2M interaction attenuates kidney fibrosis
JCI Insight · 2025
DOI: 10.1172/jci.insight.183998 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2025. Verfasst von Jackie Trink und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Hauptthemen laut MEDLINE: alpha-Macroglobulins, Heat-Shock Proteins, Kidney. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research, Diabetes Canada, Lundbeck Foundation.
Abstract (Originalsprache)
We recently showed that cell surface translocation of the endoplasmic reticulum–resident protein GRP78, when bound by activated α 2-macroglobulin (α2M*), induces pro-fibrotic responses in glomerular mesangial cells in response to high glucose and regulates activation of the pro-fibrotic cytokine transforming growth factor-β1 (TGF-β1), implicating a pathogenic role in glomerulosclerosis. Interstitial fibrosis, largely mediated by proximal tubular epithelial cells (PTEC) and renal fibroblasts, develops later in kidney disease and correlates with functional decline. Here we investigated whether interstitial fibrosis was mediated by cell surface GRP78 (csGRP78)/α2M*. High glucose and TGF-β1 increased csGRP78 and α2M* in PTEC and renal fibroblasts, and their inhibition prevented fibrotic protein production. Interestingly, for TGF-β1, this depended on inhibition of noncanonical signaling through YAP/TAZ, with Smad3 activation unaffected. In vivo, type 1 diabetic Akita mice overexpressing TGF-β1 were treated with either a neutralizing antibody for csGRP78 (C38) or α2M* (Fα2M) or an inhibitory peptide blocking csGRP78/α2M* interaction, and mice with unilateral ureteral obstruction were treated with Fα2M or inhibitory peptide. Consistently, inhibition by antibody or peptide attenuated fibrosis and pro-fibrotic signaling. These findings show an important role for csGRP78/α2M* in mediating tubulointerstitial fibrosis in both diabetic and nondiabetic kidney disease and support their inhibition as a potential antifibrotic therapeutic intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
- Department of Molecular Medicine-Cancer and Inflammation, University of Southern Denmark, Odense, Denmark.
- Department of Chemistry and Chemical Biology and.
- Department of Health Research Methods, McMaster University, Hamilton, Ontario, Canada.
- Thrombosis and Atherosclerosis Research Institute (TaARI), Hamilton, Ontario, Canada.
- Department of Physiology, Dokkyo Medical University, Mibu, Japan.
Förderung
- Canadian Institutes of Health Research
- Diabetes Canada
- Lundbeck Foundation
Zitieren
APA
Trink, J., Nmecha, I. K., Pilely, K., Li, R., Yang, Z., Kwiecien, S., MacDonald, M., Gao, B., Mamai, M. A., Lu, C., Bajwa, U. F., Uppal, N., Fredenburgh, J. C., Kakoki, M., Pizzo, S. V., Rullo, A. F., Lanktree, M. B., Weitz, J. I., Palarasah, Y., & Krepinsky, J. C. (2025). Inhibition of cell surface GRP78 and activated α2M interaction attenuates kidney fibrosis. JCI Insight. https://doi.org/10.1172/jci.insight.183998
Vancouver
Trink J, Nmecha IK, Pilely K, Li R, Yang Z, Kwiecien S, et al. Inhibition of cell surface GRP78 and activated α2M interaction attenuates kidney fibrosis. JCI Insight. 2025. doi:10.1172/jci.insight.183998
BibTeX
@article{Trink2025,
author = {Trink, Jackie and Nmecha, Ifeanyi Kennedy and Pilely, Katrine and Li, Renzhong and Yang, Zi and Kwiecien, Sydney and MacDonald, Melissa and Gao, Bo and Mamai, Mariam A and Lu, Chao and Bajwa, Urooj F and Uppal, Nikhil and Fredenburgh, James C and Kakoki, Masao and Pizzo, Salvatore V and Rullo, Anthony F and Lanktree, Matthew B and Weitz, Jeffrey I and Palarasah, Yaseelan and Krepinsky, Joan C},
title = {Inhibition of cell surface GRP78 and activated α2M interaction attenuates kidney fibrosis},
journal = {JCI Insight},
year = {2025},
doi = {10.1172/jci.insight.183998}
}
EUVIMED